BIOMARIN PHARMACEUTICAL INC Insider Trading for February 2016
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in BIOMARIN PHARMACEUTICAL INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in BIOMARIN PHARMACEUTICAL INC for February 2016.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 26 2016 | BMRN | BIOMARIN PHARMACEU ... | BAFFI ROBERT | EVP, Technical Oper ... | Grant | A | 0.00 | 5,883 | 0 | 169,709 | 163.8 K to 169.7 K (+3.59 %) |
| Feb 26 2016 | BMRN | BIOMARIN PHARMACEU ... | BAFFI ROBERT | EVP, Technical Oper ... | Grant | A | 0.00 | 49,600 | 0 | 163,826 | 114.2 K to 163.8 K (+43.42 %) |
| Feb 26 2016 | BMRN | BIOMARIN PHARMACEU ... | BAFFI ROBERT | EVP, Technical Oper ... | Grant | A | 0.00 | 17,150 | 0 | 114,226 | 97.1 K to 114.2 K (+17.67 %) |
| Feb 26 2016 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Grant | A | 0.00 | 21,978 | 0 | 543,482 | 521.5 K to 543.5 K (+4.21 %) |
| Feb 26 2016 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Grant | A | 0.00 | 198,400 | 0 | 521,504 | 323.1 K to 521.5 K (+61.40 %) |
| Feb 26 2016 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Grant | A | 0.00 | 94,850 | 0 | 323,104 | 228.3 K to 323.1 K (+41.55 %) |
| Feb 26 2016 | BMRN | BIOMARIN PHARMACEU ... | Davis George Eric | EVP, General Counse ... | Grant | A | 0.00 | 5,328 | 0 | 98,022 | 92.7 K to 98 K (+5.75 %) |
| Feb 26 2016 | BMRN | BIOMARIN PHARMACEU ... | Davis George Eric | EVP, General Counse ... | Grant | A | 0.00 | 19,840 | 0 | 92,694 | 72.9 K to 92.7 K (+27.23 %) |
| Feb 26 2016 | BMRN | BIOMARIN PHARMACEU ... | Davis George Eric | EVP, General Counse ... | Grant | A | 0.00 | 6,860 | 0 | 72,854 | 66 K to 72.9 K (+10.39 %) |
| Feb 26 2016 | BMRN | BIOMARIN PHARMACEU ... | FUCHS HENRY J | EVP, Chief Medical ... | Grant | A | 0.00 | 7,437 | 0 | 160,383 | 152.9 K to 160.4 K (+4.86 %) |
| Feb 26 2016 | BMRN | BIOMARIN PHARMACEU ... | FUCHS HENRY J | EVP, Chief Medical ... | Grant | A | 0.00 | 59,520 | 0 | 152,946 | 93.4 K to 152.9 K (+63.71 %) |
| Feb 26 2016 | BMRN | BIOMARIN PHARMACEU ... | FUCHS HENRY J | EVP, Chief Medical ... | Grant | A | 0.00 | 20,580 | 0 | 93,426 | 72.8 K to 93.4 K (+28.25 %) |
| Feb 26 2016 | BMRN | BIOMARIN PHARMACEU ... | Ajer Jeffrey Robert | SVP, Chief Commerci ... | Grant | A | 0.00 | 5,883 | 0 | 68,188 | 62.3 K to 68.2 K (+9.44 %) |
| Feb 26 2016 | BMRN | BIOMARIN PHARMACEU ... | Ajer Jeffrey Robert | SVP, Chief Commerci ... | Grant | A | 0.00 | 19,840 | 0 | 62,305 | 42.5 K to 62.3 K (+46.72 %) |
| Feb 26 2016 | BMRN | BIOMARIN PHARMACEU ... | Ajer Jeffrey Robert | SVP, Chief Commerci ... | Grant | A | 0.00 | 6,860 | 0 | 42,465 | 35.6 K to 42.5 K (+19.27 %) |
| Feb 26 2016 | BMRN | BIOMARIN PHARMACEU ... | SPIEGELMAN DANIEL K | EVP, Chief Financia ... | Grant | A | 0.00 | 5,883 | 0 | 101,077 | 95.2 K to 101.1 K (+6.18 %) |
| Feb 26 2016 | BMRN | BIOMARIN PHARMACEU ... | SPIEGELMAN DANIEL K | EVP, Chief Financia ... | Grant | A | 0.00 | 49,600 | 0 | 95,194 | 45.6 K to 95.2 K (+108.79 %) |
| Feb 26 2016 | BMRN | BIOMARIN PHARMACEU ... | SPIEGELMAN DANIEL K | EVP, Chief Financia ... | Grant | A | 0.00 | 17,150 | 0 | 45,594 | 28.4 K to 45.6 K (+60.29 %) |
| Feb 23 2016 | BMRN | BIOMARIN PHARMACEU ... | GREY MICHAEL G | Director | Option Exercise | M | 38.59 | 7,500 | 289,425 | 0 | |
| Feb 23 2016 | BMRN | BIOMARIN PHARMACEU ... | GREY MICHAEL G | Director | Sell | S | 80.00 | 7,500 | 600,000 | 26,250 | 33.8 K to 26.3 K (-22.22 %) |
| Feb 23 2016 | BMRN | BIOMARIN PHARMACEU ... | GREY MICHAEL G | Director | Buy | M | 38.59 | 7,500 | 289,425 | 33,750 | 26.3 K to 33.8 K (+28.57 %) |